Extended Infusion Carfilzomib on a Weekly Schedule in Patients With Advanced Solid Tumors
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Neoplasms|Malignancies
Interventions: DRUG: Carfilzomib|DRUG: Dexamethasone
Sponsor: Emory University
Collaborators: Amgen